BIOMAT Database Logo BIOMAT Database Logo

Safety of high-dose amphotericin B lipid complex. 1999

S Singhal, and J G Hastings, and D J Mutimer

UI MeSH Term Description Entries
D010713 Phosphatidylcholines Derivatives of PHOSPHATIDIC ACIDS in which the phosphoric acid is bound in ester linkage to a CHOLINE moiety. Choline Phosphoglycerides,Choline Glycerophospholipids,Phosphatidyl Choline,Phosphatidyl Cholines,Phosphatidylcholine,Choline, Phosphatidyl,Cholines, Phosphatidyl,Glycerophospholipids, Choline,Phosphoglycerides, Choline
D010715 Phosphatidylglycerols A nitrogen-free class of lipids present in animal and particularly plant tissues and composed of one mole of glycerol and 1 or 2 moles of phosphatidic acid. Members of this group differ from one another in the nature of the fatty acids released on hydrolysis. Glycerol Phosphoglycerides,Monophosphatidylglycerols,Phosphatidylglycerol,Phosphatidyl Glycerol,Glycerol, Phosphatidyl,Phosphoglycerides, Glycerol
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000666 Amphotericin B Macrolide antifungal antibiotic produced by Streptomyces nodosus obtained from soil of the Orinoco river region of Venezuela. Amphocil,Amphotericin,Amphotericin B Cholesterol Dispersion,Amphotericin B Colloidal Dispersion,Fungizone
D000935 Antifungal Agents Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. Anti-Fungal Agents,Antifungal Agent,Fungicides, Therapeutic,Antibiotics, Antifungal,Therapeutic Fungicides,Agent, Antifungal,Anti Fungal Agents,Antifungal Antibiotics
D001228 Aspergillosis Infections with fungi of the genus ASPERGILLUS. Aspergillus Infection,Aspergilloses,Aspergillus Infections,Infection, Aspergillus,Infections, Aspergillus

Related Publications

S Singhal, and J G Hastings, and D J Mutimer
[Amphotericin B--lipid complex].
January 1997, Enfermedades infecciosas y microbiologia clinica,
S Singhal, and J G Hastings, and D J Mutimer
Amphotericin B lipid complex.
October 1997, The Annals of pharmacotherapy,
S Singhal, and J G Hastings, and D J Mutimer
Dose-dependent pharmacokinetics of amphotericin B lipid complex in rabbits.
August 2000, Antimicrobial agents and chemotherapy,
S Singhal, and J G Hastings, and D J Mutimer
Safety of aerosolized amphotericin B lipid complex in lung transplant recipients.
August 2001, Transplantation,
S Singhal, and J G Hastings, and D J Mutimer
Study of renal safety in amphotericin B lipid complex-treated patients.
May 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
S Singhal, and J G Hastings, and D J Mutimer
The safety of amphotericin B lipid complex in patients with prior severe intolerance to liposomal amphotericin B.
March 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
S Singhal, and J G Hastings, and D J Mutimer
Biliary excretion of amphotericin B deoxycholate and amphotericin B lipid complex.
January 2000, Scandinavian journal of infectious diseases,
S Singhal, and J G Hastings, and D J Mutimer
Comparative safety, tolerance, and pharmacokinetics of amphotericin B lipid complex and amphotericin B desoxycholate in healthy male volunteers.
August 1991, The Journal of infectious diseases,
S Singhal, and J G Hastings, and D J Mutimer
Renal effects of amphotericin B lipid complex.
May 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation,
S Singhal, and J G Hastings, and D J Mutimer
The use of amphotericin B lipid complex.
February 1997, The Journal of antimicrobial chemotherapy,
Copied contents to your clipboard!